ep. 10: how has the mcrpc treatment landscape changed?
Published 4 years ago • 359 plays • Length 8:21Download video MP4
Download video MP3
Similar videos
-
6:13
ep. 7: current treatment and imaging options for nmcrpc
-
1:23
the evolving treatment landscape of mhspc and mcrpc
-
3:55
optimal treatment approaches for mcrpc
-
3:06
how ar therapy has changed the nmcrpc treatment landscape
-
8:09
treating mcrpc with newer hormonal agents
-
5:23
stories of advanced prostate cancer remissions | ask a prostate cancer expert, mark scholz, md
-
9:37
unnecessary diagnosis and treatment of prostate cancer | urochannel
-
22:00
how i live with stage 4 metastatic prostate cancer | mark's story | the patient story
-
5:20
ep. 11: factors in selecting therapy for mcrpc
-
4:32
nonmetastatic crpc: the changing landscape of treatment
-
7:07
treatment landscape of castrate-resistant prostate cancer
-
10:33
ep. 12: what is radium 223’s role in mcrpc management?
-
11:00
treatment approaches for newly diagnosed mcrpc
-
3:01
about advanced (metastatic) prostate cancer
-
1:34
investigating the treatment of unselected mcrpc patients with a cdk 4/6 inhibitor plus abemaciclib
-
11:37
multidisciplinary approach to mcrpc treatment
-
8:47
treatment of metastatic crpc
-
6:53
perspectives on metastatic hormone-sensitive prostate cancer | bayer
-
4:46
quality of life and new therapeutic options for metastatic castration-resistant prostate cancer
-
8:22
ep. 9: neurological aes and quality of life in treating nmcrpc
-
5:05
castrate resistant, non-metastatic prostate cancer (m0 state) | prostate cancer staging guide
-
16:57
navigating through the changing treatment landscape of advanced prostate cancer